Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Longholder99on Jul 28, 2022 12:19pm
183 Views
Post# 34857298

RE:RE:RE:RE:Latest paper on TLD1433

RE:RE:RE:RE:Latest paper on TLD1433Just like their approach to Cancer. Therelase will destroy Covid 19 at the cellular level rather than tricking the immune system into recognizing one strain or variant. The resulting pieces of that virus (or cancerous cell) to be used to train the body to instantly destroy it again if needed. The early investors on this company should be looked upon like those who bought into Apple back when it came out of Wozniak's garage. How many quiet millionaires were made in those days. Regular folks who just said 'ya I can see that will go somewhere'. Thanks to SF on confirming post today. Always nice to watch the foundation being built.
<< Previous
Bullboard Posts
Next >>